Application of Engineering Efferocytosis-Mimicking Nanovesicles in Atherosclerosis Treatment via M1 Macrophages and celluar lipid metabolic reprogramming
Fields of Study & Subjects
Atherosclerosis and Cardiovascular Diseases
Nanoparticle-Based Drug Delivery
Cholesterol and Lipid Metabolism
Publication details
- Journal / source
- Research Square
- Publication date
- 9 February 2026
- Language
- EN
- Document type
- Preprint